These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14625471)

  • 1. Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humans.
    Marsik C; Halama T; Cardona F; Wlassits W; Mayr F; Pleiner J; Jilma B
    Shock; 2003 Dec; 20(6):493-6. PubMed ID: 14625471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century.
    Pinti M; Troiano L; Nasi M; Bellodi C; Ferraresi R; Mussi C; Salvioli G; Cossarizza A
    Circulation; 2004 Nov; 110(19):3108-14. PubMed ID: 15505087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas ligand mRNA levels of circulating leukocytes reflect endothelial dysfunction in hyperlipidemic but not in non-hyperlipidemic patients.
    Kotani N; Fukuo K; Yasuda O; Sugimoto K; Katuya T; Takemura Y; Kawamoto H; Yokoi T; Suzuki A; Ogihara T
    Hypertens Res; 2006 Apr; 29(4):217-25. PubMed ID: 16778328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
    Ryan AE; Shanahan F; O'Connell J; Houston AM
    Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis.
    Bühling F; Wille A; Röcken C; Wiesner O; Baier A; Meinecke I; Welte T; Pap T
    Respir Res; 2005 Apr; 6(1):37. PubMed ID: 15833141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxemia enhances expression of the signaling receptor (GP130) on protein and molecular level.
    Marsik C; Halama T; Cardona F; Schlifke I; Mittermayer F; Jilma B
    Clin Immunol; 2005 Mar; 114(3):293-8. PubMed ID: 15721840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1beta sensitizes rat intervertebral disc cells to Fas ligand mediated apoptosis in vitro.
    Cui LY; Liu SL; Ding Y; Huang DS; Ma RF; Huang WG; Hu BS; Pan QH
    Acta Pharmacol Sin; 2007 Oct; 28(10):1671-6. PubMed ID: 17883956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes.
    Brown SB; Savill J
    J Immunol; 1999 Jan; 162(1):480-5. PubMed ID: 9886423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Fas, FasL, and soluble Fas mRNA in endomyocardial biopsies of human cardiac allografts.
    Pérez EC; Shulzhenko N; Morgun A; Diniz RV; Almeida DR; Musatti CC; Gerbase-DeLima M
    Hum Immunol; 2006; 67(1-2):22-6. PubMed ID: 16698421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
    Ogawa S; Nagao M; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Nakajima Y
    Anticancer Res; 2004; 24(3a):1569-79. PubMed ID: 15274324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neither Fas ligand nor endotoxin is responsible for inducible peritoneal phagocyte apoptosis during sepsis/peritonitis.
    Chung CS; Song GY; Moldawer LL; Chaudry IH; Ayala A
    J Surg Res; 2000 Jun; 91(2):147-53. PubMed ID: 10839964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis.
    Martin JH; Potthoff A; Ledig S; Cornberg M; Jandl O; Manns MP; Kubicka S; Flemming P; Athmann C; Beil W; Wagner S
    Helicobacter; 2004 Oct; 9(5):371-86. PubMed ID: 15361075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of FasL/Fas in human trophoblasts: possible implications for chorioamnionitis.
    Balkundi DR; Ziegler JA; Watchko JF; Craven C; Trucco M
    Biol Reprod; 2003 Aug; 69(2):718-24. PubMed ID: 12700199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.
    Nadal C; Maurel J; Gallego R; Castells A; Longarón R; Marmol M; Sanz S; Molina R; Martin-Richard M; Gascón P
    Clin Cancer Res; 2005 Jul; 11(13):4770-4. PubMed ID: 16000573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of Fas ligand-induced apoptosis by MUC1 mucin.
    Chaturvedi R; Srivastava RK; Hisatsune A; Shankar S; Lillehoj EP; Kim KC
    Int J Oncol; 2005 May; 26(5):1169-76. PubMed ID: 15809706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of Fas receptor on alveolar macrophages and inflammatory effects of soluble Fas ligand following blunt chest trauma.
    Seitz DH; Palmer A; Niesler U; Braumüller ST; Bauknecht S; Gebhard F; Knöferl MW
    Shock; 2011 Jun; 35(6):610-7. PubMed ID: 21330946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy.
    Kim R; Emi M; Tanabe K; Uchida Y; Toge T
    Cancer; 2004 Jun; 100(11):2281-91. PubMed ID: 15160330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.